Bvf Inc Ikena Oncology, Inc. Transaction History

Bvf Inc

$2.67 Billion
Q4 2024

A detailed history of Bvf Inc transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Bvf Inc holds 4,006,564 shares of IKNA stock, worth $5.81 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

4,006,564

Previous 4,769,164 15.99%

Holding current value

$5.81 Million

Previous $8.25 Million 20.36%

% of portfolio

0.25%

Previous 0.26%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.53 - $1.76 $1.17 Million - $1.34 Million	-762,600 Reduced 15.99%	4,006,564 $6.57 Million
Q4 2023 Feb 14, 2024	BUY	$1.33 - $4.4 $2.13 Million - $7.04 Million	1,600,000 Added 50.49%	4,769,164 $9.4 Million
Q1 2023 May 15, 2023	BUY	$2.62 - $4.97 $1.75 Million - $3.31 Million	666,093 Added 26.61%	3,169,164 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$3.23 - $7.4 $4,845 - $11,100	1,500 Added 0.06%	2,503,071 $11.1 Million
Q1 2022 May 16, 2022	BUY	$5.61 - $13.85 $3.94 Million - $9.74 Million	703,200 Added 39.1%	2,501,571 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$10.52 - $16.96 $354,524 - $571,552	-33,700 Reduced 1.84%	1,798,371 $22.6 Million
Q3 2021 Nov 15, 2021	BUY	$9.82 - $15.23 $635,079 - $984,954	64,672 Added 3.66%	1,832,071 $23.1 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $26.0 $2.23 Million - $4.36 Million	167,741 Added 10.49%	1,767,399 $24.8 Million
Q1 2021 May 17, 2021	BUY	$25.6 - $32.0 $41 Million - $51.2 Million	1,599,658 New	1,599,658 $45.2 Million

Others Institutions Holding IKNA

# of Institutions

Shares Held

31.9M

Call Options Held

Put Options Held

View Full List

About Ikena Oncology, Inc.

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $52.6M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

More about IKNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account